Progress report on the coronavirus pandemic (Q98568681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

title

Progress report on the coronavirus pandemic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

publication date

1 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

volume

584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

issue

7821

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

page(s)

325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

A new coronavirus associated with human respiratory disease in China

23 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Cryptic transmission of SARS-CoV-2 in Washington State

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

SARS-CoV-2 Infection in Children

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Multiorgan and Renal Tropism of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Extrapulmonary manifestations of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

Temporal dynamics in viral shedding and transmissibility of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FD41586-020-02414-1

7 January 2021

10.1038/D41586-020-02414-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32814893%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

1 reference